Literature DB >> 16432196

The central region of HDM2 provides a second binding site for p53.

Grace W Yu1, Stefan Rudiger, Dmitry Veprintsev, Stefan Freund, M Rosario Fernandez-Fernandez, Alan R Fersht.   

Abstract

HDM2 is a negative regulator of p53 that inhibits its transcriptional activity and subjects it to degradation by an E3 ligase activity. The primary binding site for HDM2 on p53 is located in its N-terminal domain. A second site on the p53 core domain (p53C) binds to an unidentified site in HDM2. We found that this site is in its acidic domain and part of the zinc finger domain by examining the interaction of full-length and domain constructs of p53 with the N-terminal region of HDM2 and peptide arrays derived from the full-length protein. NMR spectroscopy showed that peptides derived from this region of HDM2 bound to residues in the specific DNA-binding site of p53C. The peptides were displaced from the site by gadd45 sequence-specific DNA. Phosphorylation of single amino acids in the central domain of HDM2 did not abolish the interaction between the HDM2-derived peptides and p53C. We speculate that this second binding site helps in stabilizing the interaction between HDM2 and p53 during p53 degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432196      PMCID: PMC1360574          DOI: 10.1073/pnas.0510343103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Posttranslational modification of MDM2.

Authors:  David W Meek; Uwe Knippschild
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

2.  Critical contribution of the MDM2 acidic domain to p53 ubiquitination.

Authors:  Hidehiko Kawai; Dmitri Wiederschain; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

3.  Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.

Authors:  Assaf Friedler; Dmitry B Veprintsev; Trevor Rutherford; Karoly I von Glos; Alan R Fersht
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

4.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

5.  The N-terminal domain of p53 is natively unfolded.

Authors:  Roger Dawson; Lin Müller; Alexander Dehner; Christian Klein; Horst Kessler; Johannes Buchner
Journal:  J Mol Biol       Date:  2003-10-03       Impact factor: 5.469

6.  Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

Authors:  J Roth; M Dobbelstein; D A Freedman; T Shenk; A J Levine
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

7.  The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.

Authors:  Patima Sdek; Haoqiang Ying; Hongwu Zheng; Alexander Margulis; Xiaoren Tang; Kui Tian; Zhi-Xiong Jim Xiao
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

8.  Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.

Authors:  Andreas C Joerger; Mark D Allen; Alan R Fersht
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

9.  Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Authors:  Yanping Zhang; Gabrielle White Wolf; Krishna Bhat; Aiwen Jin; Theresa Allio; William A Burkhart; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Solution structure of the C4 zinc finger domain of HDM2.

Authors:  Grace W Yu; Mark D Allen; Antonina Andreeva; Alan R Fersht; Mark Bycroft
Journal:  Protein Sci       Date:  2005-12-29       Impact factor: 6.725

View more
  67 in total

1.  Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage.

Authors:  Qian Cheng; Brittany Cross; Baozong Li; Lihong Chen; Zhenyu Li; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

2.  Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.

Authors:  Saravanakumar Iyappan; Hans-Peter Wollscheid; Alejandro Rojas-Fernandez; Andreas Marquardt; Hao-Cheng Tang; Rajesh K Singh; Martin Scheffner
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

Review 3.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.

Authors:  Xiaoyong Fu; Nur Yucer; Shangfeng Liu; Muyang Li; Ping Yi; Jung-Jung Mu; Tao Yang; Jessica Chu; Sung Yun Jung; Bert W O'Malley; Wei Gu; Jun Qin; Yi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-19       Impact factor: 11.205

5.  The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.

Authors:  Ashley L Craig; Jennifer A Chrystal; Jennifer A Fraser; Nathalie Sphyris; Yao Lin; Ben J Harrison; Mary T Scott; Irena Dornreiter; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

6.  Ubiquitination and degradation of mutant p53.

Authors:  Natalia Lukashchuk; Karen H Vousden
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

7.  A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.

Authors:  Bartosz Wawrzynow; Susanne Pettersson; Alicja Zylicz; Janice Bramham; Erin Worrall; Ted R Hupp; Kathryn L Ball
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

8.  Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2.

Authors:  Chen Katz; Hadar Benyamini; Shahar Rotem; Mario Lebendiker; Tsafi Danieli; Anat Iosub; Hadar Refaely; Monica Dines; Vered Bronner; Tsafrir Bravman; Deborah E Shalev; Stefan Rüdiger; Assaf Friedler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

9.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

10.  Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.

Authors:  Leixiang Yang; Tanjing Song; Qian Cheng; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.